155) re-organisation in individuals receiving treatment for MSD, including their prognos |
156) medical literature to determine the best treatment for a given problem is challengi |
157) Epilepsy surgery is an effective and safe treatment for a subset of people with DRE |
158) evidence on the effect of corticosteroid treatment for acute/acute-on-chronic pancr |
159) itute for Health and Care Excellence as a treatment for depression. |
160) t exploring the safest and most effective treatment for genitourinary syndrome of me |
161) recommend 5-mg lemborexant as an initial treatment for insomnia, followed by 10-mg |
162) istance, and prioritising primary disease treatment for low-risk patients. |
163) For children who receive treatment for mental illness, having a par |
164) trate of MtrD, and a last-resort clinical treatment for multidrug-resistant gonorrhe |
165) us about the definition or most effective treatment for neglect syndrome. |
166) ies showed acupuncture to be an effective treatment for sciatic pain, however, furth |
167) ture supports acupuncture as an effective treatment for sciatica. |
168) societal loss, and there is no effective treatment for these disorders. |
169) n reproductive-age women, and no definite treatment for this disorder is without sev |
170) otherapy is the most promising new cancer treatment for various pediatric tumors and |
171) Treatment with 1% TFA with/without 2% trii |
172) Treatment with AAA-derived metabolites in |
173) Treatment with Bacillus Calmette Guerin (B |
174) Treatment with DBZ suppressed CSE-dependen |
175) Treatment with anti-inflammatory corticost |
176) Treatment with leptin, acute or chronic, w |
177) Treatment with organic solvents and post t |
178) ed with cell death were identified by pre-treatment with the CDK4/6 inhibitor palboc |
179) in in wild-type mice without and with pre-treatment with the broad-spectrum MRP inhi |
180) Combined treatment with DAC and a Bcl2 inhibitor, v |
181) We show that long-term treatment with PARPi induces an inflammato |
182) of metabolites in SF mice associated with treatment with either LR or LGG. |
183) lly compares an intervention to a control treatment with equal numbers of patients r |
184) ation cycles, and each cycle comprised of treatment with high salt (Δ0.035 M NaCl) |
185) However, a two-week treatment with iloperidone (1 mg/kg ip.) p |
186) Two-week treatment with lithium chloride partially |
187) approaches combined with pharmacological treatment with synthetic adropin peptide. |
|